3Vote!
DeviceSpace (Free subscription) | 11/06/2009
Reuters -- Medical device maker Boston Scientific Corp reached an agreement with the U.S. Department of Justice related to product recalls issued by its Guidant subsidiary, and will record a third-quarter charge of $294 million, the company said in a government filing.
4Vote!
PR News Wire (Free subscription) | 11/06/2009
NATICK, Mass., Nov. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant.
5Vote!
Red Orbit (Free subscription) | 11/06/2009
NATICK, Mass., Nov. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005.
3Vote!
DeviceSpace (Free subscription) | 11/02/2009
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our...
5Vote!
Red Orbit (Free subscription) | 11/02/2009
NATICK, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS® Element(TM) Everolimus-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent (DES) technology.
4Vote!
The Earth Times Online Newspaper (Free subscription) | 10/22/2009
CHICAGO - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Morgan Stanley (NYSE:
4Vote!
Business Wire (Free subscription) | 10/22/2009
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Morgan Stanley (NYSE: MS), Goldman Sachs (NYSE: GS), St. Jude Medical, Inc. (NYSE: STJ), Medtronic Inc. (NYSE: MDT) and Boston Scientific...
3Vote!
Medical Device Recalls since November 03, 2006 (Free subscription) | 10/22/2009
Boston Scientific Liberte¿¿ Monorail¿ and Over-the-Wire Coronary Stent Systems to be relabeled as VeriFLEX". The Liberte¿¿ Coronary Stent System consists of a balloon expandable stainless steel stent, pre-mounted on either a Liberte¿ Monorail¿ (MR) or Liberte Over-the-Wire (OTW) delivery system. The Liberte¿ system comes in stent diameters...
3Vote!
DeviceSpace (Free subscription) | 10/21/2009
CHICAGO, Oct 20 (Reuters) - Shares of Boston Scientific Corp (BSX.N) plummeted as much as 17 percent on Tuesday, wiping out $2.55 billion of market value, after the company cut its profit outlook and its chief executive warned of dire consequences from a proposed health reform tax.
5Vote!
SeekingAlpha.com (Free subscription) | 10/20/2009
Zacks.com submits: Boston Scientific Corporation (BSX ) Monday reported financial results for the third quarter of fiscal 2009 after the market close. Earnings per share were 19 cents, beating the Zacks Consensus Estimate by 5 cents and the year-ago earnings by 3 cents. Sales Complete Story »
5Vote!
PR News Wire (Free subscription) | 10/19/2009
NATICK, Mass., Oct. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2009, as well as guidance for net sales and earnings per share (EPS) for the fourth quarter and full year 2009.
4Vote!
The Earth Times Online Newspaper (Free subscription) | 10/19/2009
NATICK, Mass., Oct. 19 -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2009, as well as guidance for net sales and earnings per share (EPS) for the fourth quarter and full year 2009. ...
3Vote!
Radon Mitigation Pittsburgh (Free subscription) | 10/12/2009
( EMAILWIRE.COM , October 12, 2009 ) Del Mar, CA - The federal government takes marine pollution seriously. Air Star Green Planet marine pollution surveillance equipment will aid in protecting ocean resources for the benefit of coastal communities while protecting fragile marine ecosystems. These surveillance systems will assist in the detection, classification and tracking of all targets of potential...
6Vote!
Red Orbit (Free subscription) | 10/09/2009
NATICK, Mass., Oct. 9 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30, 2009 on Tuesday, October 20, at 8:00 a.m.
3Vote!
DeviceSpace (Free subscription) | 10/06/2009
NATICK, Mass., Oct. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its WallFlex((R)) Biliary RX fully and partially covered stents for the palliative treatment of malignant bile duct strictures. The WallFlex Biliary RX uncovered stent was cleared by the FDA...